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Aim: To investigate choroidal thickness in healthy Turkish subjects.
Materials and methods: Refraction, axial length (AXL) measurement, anterior chamber, and fundus examinations were performed.
Eyes that had any retinal or choroidal pathology were excluded from the study. Enhanced-depth imaging optical coherence tomography
was used to evaluate choroidal thickness.
Results: 139 eyes from 70 subjects were investigated. The mean age, AXL, spherical equivalent refractive error (SE), and subfoveal
choroidal thickness (SCT) were 32.9 ± 11.6 years, 23.31 ± 0.91 mm, –0.15 ± 1.64 diopters (D), and 326 ± 60 µm, respectively. A negative
correlation was found between SCT and AXL (P = 0.043). The mean age, SE, AXL, and SCT were 31.7 ± 9.3 and 34.6 ± 14.3 years, –0.27
± 1.45 and 0.02 ± 1.89 D, 23.52 ± 0.94 and 23.02 ± 0.75 mm, and 324 ± 69 and 329 ± 40 µm in male and female subjects, respectively (P
= 0.14, P = 0.31, P = 0.001, and P = 0.58, respectively). Regression analysis showed that SCT decreased by 0.93 µm for each year of age.
Conclusion: In healthy Turkish subjects, SCT decreased by 0.93 µm for each year of age and was thicker in men when the results were
adjusted according to AXL measurements.
Key words: Choroidal thickness, EDI OCT

1. Introduction
The choroid carries oxygen and metabolites to the
prelaminar side of the optic nerve and outer segment
of the retina, absorbs the excess light penetrating to the
retina and retinal pigment epithelium (RPE) with the aid
of the melanocytes that it contains, and acts as a heat sink
in many psychological events. The choroidal blood flow is
the highest blood flow per tissue mass in the human body
(1–3). The choroid cannot be fully investigated via choroid
ophthalmoscopy, fundus picture, and fundus fluorescent
angiography because of the pigments contained by the
choroid and RPE. In addition, it is hard to obtain a full
layer image, and information on cross-sectional anatomy
of the choroid cannot be obtained. B-Scan ultrasound
was used in order to obtain cross-sectional images of the
choroid (4). However, resolution was not at the desired
level, and since different cross-sections were obtained in
each examination, it is a method with weak repeatability.
Enhanced-depth imaging optical coherence tomography
(EDI OCT) technologies permit deeper penetration through
RPE and a better visualization of the choroid. Studies in
healthy individuals and in patients with age-related macular
* Correspondence: drerolcoskun@yahoo.com
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degeneration (AMD), central serous chorioretinopathy
(CSC), high myopia, and glaucoma that investigated
the choroidal thickness were performed by using EDI
OCT technologies (5–10). It was reported that choroidal
thickness may differ according to ethnicity; therefore, many
studies assessing the normal mean choroidal thickness in
different ethnic groups were performed (6,7). In this study,
the normal choroidal thickness values in healthy Turkish
individuals are investigated.
2. Materials and methods
The study group consisted of the volunteers who were
examined in our clinics between February 2012 and
January 2013. Refraction, axial length (AXL) measurement,
uncorrected visual acuity, best corrected visual acuity,
intraocular pressure, anterior chamber, and dilated fundus
examinations were performed on all individuals. Exclusion
criteria included diabetes mellitus, hypertension, history of
intraocular surgery, photodynamic therapy, transpupillary
thermotherapy, focal laser treatment, ionizing radiation,
uveitis, AMD, CSC, glaucoma, amblyopia, high myopia,
and poor image quality due to severe cataract. Gaziantep
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University ethics committee approval and informed
consents from all patients in accordance with the
Declaration of Helsinki were obtained.
2.1. Measurement protocol
All EDI OCT measurements were performed by the same
clinician (R.Y.) between 1430 and 1600 hours. EDI OCT
was performed using Heidelberg Spectralis equipment
(Heidelberg Engineering Inc., Heidelberg, Germany)
for both eyes of each participant. The EDI OCT images
were obtained based on a previously described method
(5). Seven sections, each comprising 100 scans using
the automatic averaging and eye tracking features, were
obtained. The horizontal section going directly through
the center of the fovea was selected.
The choroidal thickness was measured from the outer
portion of the hyperreflective line corresponding to the
RPE to the inner surface of the sclera (Figure 1). The
choroidal thicknesses at the fovea, 3 mm nasal to the fovea,
and 3 mm temporal to the fovea were measured. Two
examiners who were masked to subjects’ refraction and
axial length (EC and RY) measured the choroidal thickness
in all subjects and the mean value of the measurements
was calculated. The eyes having more than 15% difference
of measurement between the 2 ophthalmologists were
excluded from the study.

Figure 1. An EDI OCT scan obtained from a 58-year-old female
subject. The choroidal thickness was measured from the RPE to
the inner surface of the sclera (arrowheads).

2.2. Statistical analysis
SPSS 11.5 for Windows (SPSS Inc., Chicago, IL, USA)
was used for statistical analyses. Data were recorded
as the mean ± standard deviation. The paired t-test was
used to analyze choroidal thickness at different locations.
The Pearson correlation test was used to investigate the
correlation between different variables. A P-value of less
than 0.05 was considered statistically significant.
3. Results
A total of 139 eyes from 28 female and 42 male patients
were included in the study. Seventy right eyes and 69 left
eyes were analyzed. The mean age of the subjects was 32.9
± 11.6 years (range: 16–70) (Figure 2). The mean AXL

Figure 2. The distribution of age of all subjects.
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was 23.31 ± 0.91 mm (range: 20.77–26.10). The mean
spherical equivalent refraction error (SE) was –0.15 ± 1.64
(range: –5.75 to 5.50) (Figure 3). The choroidal thickness
measurements of the 2 examiners were significantly
correlated (correlation coefficient: 0.843, P < 0.01). The
mean choroidal thickness at subfoveal, nasal, and temporal
sites was 326 ± 60, 179 ± 58, and 240 ± 55 µm, respectively
(Table).
There were significant differences between subfoveal
thickness and each extrafoveal choroidal thickness (P
< 0.01 to P < 0.01). There was significant correlation
between choroidal thickness measurements at subfoveal
and at nasal and temporal locations (P < 0.01 and P < 0.01,
respectively). A negative correlation was found between
age and the choroidal thickness at subfoveal, temporal,
and nasal locations (P = 0.03, P = 0.02, and P = 0.04,
respectively) (Figure 4).
A negative correlation was found between SE and
the choroidal thickness at subfoveal, temporal, and nasal
locations (P = 0.034, P = 0.019, and P = 0.037, respectively).
A negative correlation was found between AXL and the
choroidal thickness at subfoveal, temporal, and nasal
locations (P = 0.043, P = 0.03, and P = 0.021, respectively).
Regression analysis demonstrated that subfoveal choroidal
thickness decreased by 0.93 µm for each year of age.

When the data from the male and female groups were
assessed as 2 different groups, the mean age was 31.7 ±
9.3 years in male subjects and 34.6 ± 14.3 years in female
subjects (P = 0.14). The mean AXL was 23.52 ± 0.94 mm
in male subjects and 23.0 ± 0.75 mm in female subjects
(P = 0.001). The mean SE was –0.27 ± 1.45 diopters (D)
in male subjects and 0.02 ± 1.89 D in female subjects (P =
0.31). The mean subfoveal choroidal thickness was 324 ±
69 µm in male subjects and 329 ± 40 µm in female subjects
(P = 0.58).
4. Discussion
Diseases such as AMD, polypoidal choroidal vasculopathy
(PCV), CSC, and high myopia are thought to result from
pathological changes in choroidal tissue (11–15). The
incidence of AMD and PCV vary according to ethnicity.
For example, wet AMD and PCV are more common in
Japanese populations compared to Caucasians (16). In a
study that assessed the AMD prevalence in Hispanic, black,
Chinese, and white patients, wet AMD was reported to be
most common among the Chinese population (17). This
may be due to environmental and genetic factors as well
as the interracial difference in choroidal structure, since
choroidal tissue plays a vital role in the pathophysiology of
both diseases. As a result, evaluation of the choroidal tissue

Figure 3. The distribution of the spherical equivalent refraction error of all subjects.
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Figure 4. Scatterplot of age and subfoveal choroidal thickness of all subjects.
Table. Demographic properties of the individuals who were
involved in the study and the measurement results of the eyes.
Age (years)

32.9 ± 11.6

Sex (male/female)

42/28

Axial length (mm)

23.31 ± 0.91

Spherical equivalent (D)

–0.15 ± 1.64

Subfoveal choroidal thickness (µm)

326 ± 60

Temporal choroidal thickness (µm)

240 ± 55

Nasal choroidal thickness (µm)

179 ± 58

in different races or ethnicities may aid in pinpointing the
diseases in which pathophysiology of the choroid plays a
role. This study, to the best of our knowledge, is the first
study that investigates the choroidal thickness in a healthy
Turkish population.
In this study, it was found out that the subfoveal,
nasal, and temporal choroidal thicknesses were inversely
proportional to the age and SE and AXL parameters of
the eye in the Turkish population. Similarly, in studies
conducted within different ethnic groups, it was reported

that there were negative correlations between choroidal
thickness and AXL and SE values (5–7). It was observed in
this study that subfoveal choroidal thickness was decreased
by 0.93 µm per age. This value was reported to be 1.56
µm in an American population, though not representing
a homogeneous society, and 1.40 µm in a Japanese
population. Although age-related choroidal thickness
decrease is a finding that is seen in all studies conducted
within different ethnic groups, the amount of decrease was
found to be different in all studies. This difference may
be because of the small size in the study group, different
software usage (for the Japanese population), errors in
manual choroidal thickness measurements, and racial
differences.
In this study, the choroidal thickness was at its thickest
in the subfoveal region, thinner at temporal 3 mm region,
and thinnest at the nasal 3 mm in the Turkish population.
Margolis and Spaide reported that choroidal thickness
decreases from the subfoveal region to the temporal and
nasal regions (5). Different studies conducted in different
ethnicities support this difference in the choroidal
thickness (7).
In our study, the mean subfoveal, nasal, and temporal
choroidal thicknesses were found to be 326, 179, and 240
µm, respectively. Margolis and Spaide reported that the
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subfoveal choroidal thickness in healthy individuals was
287 µm, while Ikuno et al. reported a thickness of 354
µm, and Li et al. a thickness of 342 µm (5–7). The fact that
the choroidal thickness in our population was found to
be thicker compared to the study of Margolis and Spaide
may be explained by our study group’s being 20 years
younger on average. When our study group is compared
to a study group that assesses the choroidal thickness in a
healthy Japanese population (6), it is seen that the Japanese
group consists of individuals that are older, more myopic,
and having eyes with longer axial lengths. When all these
factors are taken into account, it is thought that this
study had to yield lower choroidal thickness values when
compared to our study, although the subfoveal choroidal
thickness in healthy Japanese subjects was found to be
approximately 30 µm thicker than in our study group. This
may be because of ethnic differences or the different kind
of instruments used. The choroidal thickness in a healthy
Danish population was found to be a little thicker than in
our group (7). This is a normal outcome since the Danish
study group was an average of 10 years younger than our
study group.
There were no statistically significant differences in
subfoveal choroidal thickness between male and female
subjects in our study. On the other hand, in studies
conducted in a healthy Danish population, male choroidal
thickness was found to be greater than that of females
(7). This difference may depend on the AXL of the male

subjects being longer than that of female subjects in our
study, and choroidal thickness is negatively correlated to
AXL. Estrogen receptors have been found in the human
RPE, and estrogen provides an antioxidant effect by
inhibiting lipid peroxidation. Related studies revealed that
patients exposed to estrogen due to hormone replacement
therapy or pregnancy had increased incidence of AMD
(18–22). Pathogenesis of AMD is multifactorial and
choroidal thickness might be playing a role in this broad
pathogenetic cycle of the disease.
This study has some limitations. To start with, we
did not have a device that measures choroidal thickness
automatically like the way it measures retinal thickness.
Therefore, this measurement was done manually.
Moreover, AXL measurements of the eyes were also done
manually. In both cases, there may be measurement errors,
and this may affect the outcome.
In conclusion, the choroidal thickness in the Turkish
population has a similar range in accordance with
the studies conducted previously. Subfoveal choroidal
thickness may differ among populations. Subfoveal
choroidal thickness shows negative correlations with age
and with SE and AXL values. The decreases in choroidal
thickness by age vary according to the populations. Due
to the antioxidant effect of estrogen in women, choroidal
thickness is decreased in women compared to men, but
choroidal thickness might be playing a role in the broad
pathogenetic cycle of some diseases.
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